Pittsburgh, PENNSYLVANIA3 Active Studies

Esophageal Cancer Clinical Trials in Pittsburgh, PENNSYLVANIA

Find 3 actively recruiting esophageal cancer clinical trials in Pittsburgh, PENNSYLVANIA. Connect with local research sites and explore new treatment options.

3
Active Trials
1
Sponsors
450
Enrolling

Recruiting Esophageal Cancer Studies in Pittsburgh

RecruitingPittsburgh, PENNSYLVANIANCT05319730

A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)

This is a Phase 1/2, multicenter, randomized, open-label umbrella platform study to evaluate the safety and efficacy of investigational agents with or without pembrolizumab and/or chemotherapy, for th...

230 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingPittsburgh, PENNSYLVANIANCT06469944

Substudy 06C: A Study of Sacituzumab Tirumotecan (MK-2870) With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

This is a phase 1/2, multicenter, open-label umbrella platform study that will evaluate the safety and tolerability of sacituzumab tirumotecan with pembrolizumab and fluoropyrimidine chemotherapy for ...

130 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingPittsburgh, PENNSYLVANIANCT06445972

Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)

This is a phase 1/2 multicenter, open-label umbrella platform study that will evaluate the safety and efficacy of sacituzumab tirumotecan (MK-2870) plus paclitaxel versus ramucirumab plus paclitaxel, ...

90 participants
Merck Sharp & Dohme LLC
View Study Details

About Esophageal Cancer Clinical Trials in Pittsburgh

Esophageal cancer occurs in the esophagus, the tube connecting the throat to the stomach. The two main types are squamous cell carcinoma and adenocarcinoma. Treatment may include surgery, chemotherapy, radiation, and immunotherapy.

There are currently 3 esophageal cancer clinical trials recruiting participants in Pittsburgh, PENNSYLVANIA. These studies are seeking a combined 450 participants. Research is being sponsored by Merck Sharp & Dohme LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.

Esophageal Cancer Clinical Trials in Pittsburgh — FAQ

Are there esophageal cancer clinical trials in Pittsburgh?

Yes, there are 3 esophageal cancer clinical trials currently recruiting in Pittsburgh, PENNSYLVANIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Pittsburgh?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Pittsburgh research site will contact you about next steps.

Are clinical trials in Pittsburgh free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Pittsburgh studies also compensate for your time and travel.

What esophageal cancer treatments are being tested?

The 3 active trials in Pittsburgh are testing new therapies including novel drugs, biologics, and treatment approaches for esophageal cancer.

Data updated March 2, 2026 from ClinicalTrials.gov